DSpace

DSpace at RU >

Search Results

 
for  

Results 1-50 of 57.

Sort items by In order  |  Results/Page Authors/record

Item hits:

Full TextIssue DateTitleAuthor(s)
2011Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium.Salles, G.; Jong, D. de; Xie, W.; Rosenwald, A.; Chhanabhai, M.; Gaulard, P.; Klapper, W.; Calaminici, M.; Sander, B.; Thorns, C.; Campo, E.; Molina, T.; Lee, A.; Pfreundschuh, M.; Horning, S.; Lister, A.; Sehn, L.H.; Raemaekers, J.M.M.; Hagenbeek, A.; Gascoyne, R.D.; Weller, E.
2011Development and measurement of guideline-based indicators for patients with non-Hodgkin's lymphomaWennekes, L.; Ottevanger, P.B.; Raemaekers, J.M.M.; Schouten, H.C.; Kok, M.W. de; Punt, C.J.A.; Grol, R.P.T.M.; Wollersheim, H.C.H.; Hermens, R.P.M.G.
2011Gem-(R)CHOP versus (R)CHOP: a randomized phase II study of gemcitabine combined with (R)CHOP in untreated aggressive non-Hodgkin's lymphoma--EORTC lymphoma group protocol 20021 (EudraCT number 2004-004635-54)Aurer, I.; Eghbali, H.; Raemaekers, J.M.; Khaled, H.M.; Fortpied, C.; Baila, L.; Maazen, R.W. van der
2010Protein profiling in pathology: analysis and evaluation of 239 frozen tissue biopsies for diagnosis of B-cell lymphomas.Jansen, C.; Feuth, T.; Raemaekers, J.M.M.; Rijntjes, J.; Meijer, J.W.; Westenend, P.J.; Baarlen, J. van; Krieken, J.H.J.M. van; Hebeda, K.M.; Groenen, P.J.T.A.
2009Richter's syndrome developing in a patient with adult onset Still's disease.Geurts, D.E.M.; Velden, W.J.F.M. van der; Hebeda, K.M.; Raemaekers, J.M.M.
2009Development and application of a real-time on-line blinded independent central review of interim PET scans to determine treatment allocation in lymphoma trials.Meignan, M.; Itti, E.; Bardet, S.; Lumbroso, J.; Edeline, V.; Olivier, P.; Borght, T.V.; Reman, O.; Karcher, G.; Mundler, O.; Mounier, N.; Ricci, R.; Federico, M.; Raemaekers, J.M.M.; Andre, M.
2009The role of rituximab in a case of EBV-related lymphoproliferative disease presenting with haemophagocytosis.Bosman, G.J.C.G.M.; Langemeijer, S.M.C.; Hebeda, K.M.; Raemaekers, J.M.M.; Pickkers, P.; Velden, W.J.F.M. van der
2009Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium).Jong, D.J. de; Xie, W.; Rosenwald, A.; Chhanabhai, M.; Gaulard, P.; Klapper, W.; Lee, A.; Sander, B.; Thorns, C.; Campo, E.; Molina, T.; Hagenbeek, A.; Horning, S.; Lister, A.; Raemaekers, J.M.M.; Salles, G.; Gascoyne, R.D.; Weller, E.
2009Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols.Jong, D.J. de; Koster, A.; Hagenbeek, A.; Raemaekers, J.M.M.; Veldhuizen, D.; Heisterkamp, S.; Boer, J.P. de; Glabbeke, M. van
2009Sperm quality before treatment in patients with early stage Hodgkin's lymphoma enrolled in EORTC-GELA Lymphoma Group trials.Kaaij, M.A. van der; Heutte, N.; Echten-Arends, J. van; Raemaekers, J.M.M.; Carde, P.; Noordijk, E.M.; Ferme, C.; Thomas, J.; Eghbali, H.; Brice, P.; Bonmati, C.; Henry-Amar, M.; Kluin-Nelemans, H.C.
2008Hodgkin's lymphoma: news from an old disease.Raemaekers, J.M.M.; Maazen, R.W.M. van der
2008Protein profiling of B-cell lymphomas using tissue biopsies: A potential tool for small samples in pathology.Jansen, C.; Hebeda, K.M.; Linkels, M.; Grefte, J.M.M.; Raemaekers, J.M.M.; Krieken, J.H.J.M. van; Groenen, P.J.T.A.
2007Aanpassing van therapie op basis van een vroege FDG-PET scan bij patiënten met een stadium I of II Hodgkin lymfoom. De H10 Intergroep studie van EORTC, GELA en IIL.Raemaekers, J.M.M.
2007Do we need an early unfavorable (intermediate) stage of Hodgkin's lymphoma?Specht, L.; Raemaekers, J.M.M.
2007Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma.Glas, A.M.; Knoops, L.; Delahaye, L.; Kersten, M.J.; Kibbelaar, R.E.; Wessels, L.A.; Laar, R. van; Krieken, J.H.J.M. van; Baars, J.W.; Raemaekers, J.M.M.; Kluin, P.M.; Veer, L.J. van 't; Jong, D. de
2007Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications--a study from the Lunenburg Lymphoma Biomarker Consortium.Jong, D. de; Rosenwald, A.; Chhanabhai, M.; Gaulard, P.; Klapper, W.; Lee, A.; Sander, B.; Thorns, C.; Campo, E.; Molina, T.; Norton, A.; Hagenbeek, A.; Horning, S.; Lister, A.; Raemaekers, J.M.M.; Gascoyne, R.D.; Salles, G.; Weller, E.
2007Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.Aleman, B.M.P.; Raemaekers, J.M.M.; Tomisic, R.; Baaijens, M.H.; Bortolus, R.; Lybeert, M.L.; Maazen, R.W.M. van der; Girinsky, T.; Demeestere, G.; Lugtenburg, P.; Lievens, Y.; Jong, D. de; Pinna, A.; Henry-Amar, M.
2007The prognostic significance of the intra-follicular tumor cell proliferative rate in follicular lymphoma.Koster, A.; Tromp, H.A.; Raemaekers, J.M.M.; Borm, G.F.; Hebeda, K.M.; MacKenzie, M.A.; Krieken, J.H.J.M. van
2007Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.Ferme, C.; Eghbali, H.; Meerwaldt, J.H.; Rieux, C.; Bosq, J.; Berger, F.; Girinsky, T.; Brice, P.; Veer, M.B. van 't; Walewski, J.A.; Lederlin, P.; Tirelli, U.; Carde, P.; Neste, E. van den; Gyan, E.; Monconduit, M.; Divine, M.; Raemaekers, J.M.M.; Salles, G.; Noordijk, E.M.; Creemers, G.J.; Gabarre, J.; Hagenbeek, A.; Reman, O.; Blanc, M.; Thomas, J.; Vie, B.; Kluin-Nelemans, J.C.; Viseu, F.; Baars, J.W.; Poortmans, P.; Lugtenburg, P.; Carrie, C.; Jaubert, J.; Henry-Amar, M.
2007Gonadal function in males after chemotherapy for early-stage Hodgkin's lymphoma treated in four subsequent trials by the European Organisation for Research and Treatment of Cancer: EORTC Lymphoma Group and the Groupe d'Etude des Lymphomes de l'Adulte.Kaaij, M.A. van der; Heutte, N.; Stang, N. Le; Raemaekers, J.M.M.; Simons, A.H.; Carde, P.; Noordijk, E.M.; Ferme, C.; Thomas, J.; Eghbali, H.; Kluin-Nelemans, H.C.; Henry-Amar, M.
2006Treatment of stage I and II hodgkin's lymphoma.Raemaekers, J.M.M.
2006Het Hodgkin lymfoom: op weg naar een behandeling op maat.Raemaekers, J.M.M.
2006A mediastinal mass after donor lymphocyte infusion for relapse of chronic myeloid leukemia after allogeneic stem cell transplantation.Schattenberg, A.V.M.B.; Baynes, C.; Dijk, M.C.R.F. van; Koster, A.; Cleef, P.H. van; Preijers, F.W.M.B.; Hermus, A.R.M.M.; Raemaekers, J.M.M.
2006Chemotherapy and radiotherapy in Hodgkin's lymphoma: joining in or splitting up?Maazen, R.W.M. van der; Raemaekers, J.M.M.
2006Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials.Franklin, J.; Pluetschow, A.; Paus, M.; Specht, L.; Anselmo, A.P.; Aviles, A.; Biti, G.; Bogatyreva, T.; Bonadonna, G.; Brillant, C.; Cavalieri, E.; Diehl, V.; Eghbali, H.; Ferme, C.; Henry-Amar, M.; Hoppe, R.; Howard, S.; Meyer, R.; Niedzwiecki, D.; Pavlovsky, S.; Radford, J.; Raemaekers, J.M.M.; Ryder, D.; Schiller, P.; Shakhtarina, S.; Valagussa, P.; Wilimas, J.; Yahalom, J.
2006Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.Noordijk, E.M.; Carde, P.; Dupouy, N.; Hagenbeek, A.; Krol, A.D.G.; Kluin-Nelemans, J.C.; Tirelli, U.; Monconduit, M.; Thomas, J.; Eghbali, H.; Aleman, B.; Bosq, J.; Vovk, M.; Verschueren, T.A.; Peny, A.M.; Girinsky, T.; Raemaekers, J.M.M.; Henry-Amar, M.
2006Extranodal marginal zone (MALT) lymphoma in common variable immunodeficiency.Desar, I.M.; Keuter, M.; Raemaekers, J.M.M.; Jansen, J.B.M.J.; Krieken, J.H.J.M. van; Meer, J.W.M. van der
2005The EORTC strategy in the treatment of Hodgkin's lymphoma.Eghbali, H.; Raemaekers, J.M.M.; Carde, P.
2005Radiotherapy in advanced-stage Hodgkin's lymphoma.Raemaekers, J.M.M.; Aleman, B.; Henry-Amar, M.
2005Angiogenesis in malignant lymphoma.Koster, A.; Raemaekers, J.M.M.
2005Late non-neoplastic events in patients with aggressive non-Hodgkin's lymphoma in four randomized European Organisation for Research and Treatment of Cancer trials.Moser, E.C.; Noordijk, E.M.; Carde, P.; Tirelli, U.; Baars, J.W.; Thomas, J.; Bron, D.; Meerwaldt, J.H.; Glabbeke, M. van; Raemaekers, J.M.M.; Kluin-Nelemans, H.C.
2005Quality control of involved-field radiotherapy in patients with advanced Hodgkin's lymphoma (EORTC 20884).Aleman, B.; Girinsky, T.; Maazen, R.W.M. van der; Strijk, S.P.; Meijnders, P.; Bortolus, R.; Olofsen-van Acht, M.J.; Lybeert, M.L.; Lievens, Y.; Eghbali, H.; Noordijk, E.M.; Tomsic, R.; Meerwaldt, J.H.; Poortmans, P.; Smit, W.G.; Pinna, A.; Henry-Amar, M.; Raemaekers, J.M.M.
2005Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma.Imhoff, G.W. van; Holt, B. van der; MacKenzie, M.A.; Ossenkoppele, G.J.; Wijermans, P.W.; Kramer, M.H.; Veer, M.B. van 't; Schouten, H.C.; Marwijk-Kooy, M. van; Oers, M.H. van; Raemaekers, J.M.M.; Sonneveld, P.; Meulendijks, L.A.; Kluin, P.; Kluin-Nelemans, H.C.; Verdonck, L.F.
2005Increased vascularization predicts favorable outcome in follicular lymphoma.Koster, A. de; Krieken, J.H.J.M. van; MacKenzie, M.A.; Schraders, M.; Borm, G.F.; Laak, J.A.W.M. van der; Leenders, W.P.J.; Hebeda, K.M.; Raemaekers, J.M.M.
2004Beyond the International Prognostic Index: new prognostic factors in follicular lymphoma and diffuse large-cell lymphoma A meeting report of the Second International Lunenburg Lymphoma Workshop.Kersten, M.; Jong, D. de; Raemaekers, J.M.M.; Kluin, P.; Hagenbeek, A.
2004Intra-follicular profileration rate is a powerful independent prognosticator in follicular lymphomaKoster, A.; Tromp, H.A.; Raemaekers, J.M.M.; Borm, G.F.; MacKenzie, M.A.; Krieken, J.H.J.M. van
2004Long-term efficacy of the CHVmP/BV regimen used for aggressive non-Hodgkin's lymphoma in three randomised EORTC trials.Moser, E.C.; Noordijk, E.M.; Glabbeke, M. van; Teodorovic, I.; Wolf-Peeters, C. de; Carde, P.; Baars, J.W.; Tirelli, U.; Raemaekers, J.M.M.; Kluin-Nelemans, J.C.
1997Absence of hepatitis C virus infection in non-Hodgkin's lymphomaThalen, D.J.; Raemaekers, J.M.M.; Galama, J.M.D.; Cooreman, M.P.R.
1997Empirical and subsequent use of antibacterial agents in the febrile neutropenic patientPauw, B.E. de; Raemaekers, J.M.M.; Schattenberg, A.V.M.B.; Donnelly, J.P.
1997Vragen rond aanvullende radiotherapie bij patiënten met de ziekte van Hodgkin stadium III of IV, in remissie na chemotherapieRaemaekers, J.M.M.
1997Regulation of the production of pro-inflammatory cytokines and antagonists during chemotherapy-induced neutropenia in patients with haematological malignanciesDenecker, N.E.J.; Kullberg, B.J.; Drenth, J.P.H.; Raemaekers, J.M.M.; Meer, J.W.M. van der
1997Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trialRaemaekers, J.M.M.; Burgers, M.; Henry-Amar, M.; Pinna, A.; Mandard, A.; Monfardini, S.; Hagenbeek, A.; Breed, W.; Carde, P.; Vovk, M.; Thomas, J.; Noordijk, E.M.
1997Clostridium septicum sepsis and neutropenic enterocolitis in a patient treated with intensive chemotherapy for acute myeloid leukemiaPouwels, M.J.M.; Donnelly, J.P.; Raemaekers, J.M.M.; Verweij, P.E.; Pauw, B.E. de
1996De nieuwe purine analogaRaemaekers, J.M.M.
1996High dose therapy followed by bone marrow transplantation for relapsed follicular non-Hodgkin's lymphomaSchouten, I.C.; Raemaekers, J.M.M.; Kluin-Nelemans, H.C.; Kamp, H. van; Mellink, W.A.M.; Veer, M.B. van 't
1996Succesvolle ambulante behandeling van patiënten met harige-cellenleukemie met één cyclus van het purineanalogon cladribineRaemaekers, J.M.M.; Veer, M.B. van 't; Bogman, M.J.J.T.
1996Diagnostiek en behandeling van het non-Hodgkin-lymfoom van lage maligniteitsgraad anno 1996Mandigers, C.M.P.W.; Raemaekers, J.M.M.; Bogman, M.J.J.T.; Pauw, B.E. de
1996Succesvolle ambulante behandeling van patienten met harige-cellenleukemie met een cyclus van het purineanalogon cladribine. Hemato-oncologie volwassenen Nederland (HOVON)-onderzoeksgroepRaemaekers, J.M.M.; Veer, M.B. van 't; Bogman, M.J.J.T.
1995Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patientsPauw, B.E. de; Donnelly, J.P.; Raemaekers, J.M.M.
1995Helicobacter pylori-infectie en lymfoom van de maagBoot, H.; Raemaekers, J.M.M.; Jong, D.J. de; Heerde, P. van; Taal, B.G.

1 2 next

 

  DSpace Software Copyright © 2002-2011  Duraspace - Feedback